LNX1 Antikörper (C-Term)
Kurzübersicht für LNX1 Antikörper (C-Term) (ABIN630139)
Target
Alle LNX1 Antikörper anzeigenReaktivität
Wirt
Klonalität
Konjugat
Applikation
-
-
Bindungsspezifität
- C-Term
-
Spezifität
- LNX1 antibody was raised against the C terminal of LNX1
-
Aufreinigung
- Purified
-
Immunogen
- LNX1 antibody was raised using the C terminal of LNX1 corresponding to a region with amino acids SHREWDLPIYVISVEPGGVISRDGRIKTGDILLNVDGVELTEVSRSEAVA
-
-
-
-
Applikationshinweise
-
WB: 1.25 µg/mL
Optimal conditions should be determined by the investigator. -
Kommentare
-
LNX1 Blocking Peptide, catalog no. 33R-8514, is also available for use as a blocking control in assays to test for specificity of this LNX1 antibody
-
Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
-
-
Format
- Lyophilized
-
Rekonstitution
- Lyophilized powder. Add distilled water for a 1 mg/mL concentration of LNX1 antibody in PBS
-
Konzentration
- Lot specific
-
Buffer
- PBS
-
Handhabung
-
Avoid repeated freeze/thaw cycles.
Dilute only prior to immediate use. -
Lagerung
- 4 °C/-20 °C
-
Informationen zur Lagerung
- Store at 2-8 °C for short periods. For longer periods of storage, store at -20 °C.
-
-
- LNX1 (Ligand of Numb-Protein X 1 (LNX1))
-
Andere Bezeichnung
- LNX1
-
Hintergrund
- LNX1 is a membrane-bound protein that is involved in signal transduction and protein interactions. LNX1 is an E3 ubiquitin-protein ligase, which mediates ubiquitination and subsequent proteasomal degradation of proteins containing phosphotyrosine binding (PTB) domains. This protein may play an important role in tumorogenesis.
-
Molekulargewicht
- 70 kDa (MW of target protein)
Target
-